Food News and Research

RSS

Study identifies potential ways to minimize acrylamide levels in french fries

The process for preparing frozen, par-fried potato strips - distributed to some food outlets for making french fries - can influence the formation of acrylamide in the fries that people eat, a new study has found. Published in ACS' Journal of Agricultural and Food Chemistry, the study identifies potential ways of reducing levels of acrylamide, which the National Toxicology Program and the International Agency for Research on Cancer regard as a "probable human carcinogen."

27 Sep 2012

Amakem commences AMA0076 Phase 2a study in glaucoma and ocular hypertension

Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.

27 Sep 2012

Forest submits levomilnacipran NDA with FDA for treatment of major depressive disorder

Forest Laboratories, Inc. and Pierre Fabre Laboratories todayannounced that Forest has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for levomilnacipran, a serotonin norepinephrine reuptake inhibitor (SNRI) for the treatment of Major Depressive Disorder (MDD) in adults.

27 Sep 2012

Viewpoints: 'Redistribution' debate; Reducing delayed, missed and incorrect diagnoses

The Affordable Care Act, which levies new taxes on the wealthy to expand access to health care for the near poor, seems on track to become the biggest increase in government redistribution since the Johnson administration.

27 Sep 2012

Dr. Reddy's introduces generic Singulair oral granules in the U.S.

Dr. Reddy's Laboratories announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market on September, 26, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr.Reddy's ANDA for Montelukast Sodium Oral Granules.

27 Sep 2012

Pfizer, Bristol-Myers Squibb report FDA acknowledgement of ELIQUIS NDA resubmission

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).

27 Sep 2012

Easy steps to protect against spread of influenza

Flu season is here and Concentra is sharing some easy steps to protect against the spread of influenza, including seasonal flu vaccines available at all Concentra locations across the country. Concentra is a subsidiary of Humana Inc., one of the nation's leading health and well-being companies

27 Sep 2012

Loyola now offers sacral nerve stimulation for patients with fecal incontinence

Fecal incontinence, or the inability to control the bowels, is a highly underreported and stigmatized condition, according to colorectal surgeons at Loyola University Health System (LUHS).

27 Sep 2012

Accera to sponsor National Memory Screening Day of Alzheimer's Foundation of America

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today that it is a silver sponsor of the Alzheimer's Foundation of America's (AFA) National Memory Screening Day (NMSD) on November 13, 2012 during National Alzheimer's Disease Awareness Month.

27 Sep 2012

Enrollment complete in Boehringer Ingelheim’s nintedanib phase III studies for IPF

Boehringer Ingelheim Pharmaceuticals, Inc. announced that clinical trial enrollment has completed for two phase III studies evaluating the safety and efficacy of nintedanib (BIBF 1120), an investigational compound, in patients with idiopathic pulmonary fibrosis (IPF), being studied at a twice-daily oral dose.

27 Sep 2012

Positive results from Sobi, Biogen Idec's rFIXFc Phase 3 trial on hemophilia B

Biogen Idec and Swedish Orphan Biovitrum (Sobi) today announced positive results from B-LONG, a clinical study that evaluated a new long-lasting clotting factor candidate in people with hemophilia B. Hemophilia B is a rare inherited disorder that impairs blood coagulation.

27 Sep 2012

Landec first quarter revenues increase 39% to $102.1 million

Landec Corporation today reported results for the first quarter of fiscal year 2013 ended August 26, 2012. Revenues increased 39% to $102.1 million compared to revenues of $73.3 million for the first quarter a year ago. Net income increased 40% to $2.5 million or $0.10 per share compared to $1.8 million or $0.07 per share for the first quarter of last year.

27 Sep 2012

Concern grows about rice-related arsenic exposure

US children who consume rice have significantly higher levels of urinary arsenic than children who do not, show study results.

26 Sep 2012

KFDA clears OrthoAccel's AcceleDent orthodontic device in South Korea

OrthoAccel Technologies has just received official clearance from the Korean Food and Drug Administration (KFDA) to begin commercial sales of its AcceleDent orthodontic device in South Korea.

26 Sep 2012

MindChild receives FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

MindChild Medical, Inc. today announced that it has received clearance for its Pre-Marketing Notification (510(k)) from the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.

26 Sep 2012

Hunger linked to increased risk of breast cancer in women

Jewish women who were severely exposed to hunger during World War Two were five times more likely to develop breast cancer than women who were mildly exposed, according to research in the October issue of IJCP, the International Journal of Clinical Practice.

26 Sep 2012

Health insurance to provide easy-to-understand plan summaries

On Monday, a health law provision goes into effect that requires insurance companies to provide user-friendly guides that provide explanations of plan benefits that will be as clear and easy to understand as the nutrition facts provided on food packages.

26 Sep 2012

Fish-oil fortified nutrition bars can provide health benefits of omega-3 fatty acids

In today's fast-paced society, consumers often reach for nutrition bars when looking for a healthy on-the-go snack. A new study in the September issue of the Journal of Food Science published by the Institute of Food Technologists (IFT) found that partially replacing canola oil with fish oil in nutrition bars can provide the health benefits of omega-3 fatty acids without affecting the taste.

26 Sep 2012

PRI examines India's efforts to combat malnutrition using local product

PRI's "The World" reports on malnutrition in India, where "eight million children ... suffer from severe acute malnutrition, according to the Indian government." However, the news service writes that "when it comes to treating those children, India lacks what many consider one of the best tools available: so-called ready-to-use therapeutic foods," such as "the most well-known therapeutic food, Plumpy'Nut, ... a patented concoction of peanut butter and micro-nutrients that allows severely malnourished children to be treated at home instead of at a hospital."

26 Sep 2012